STAT News

STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise

Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent injections compared to a standard treatment.

By STAT News

1 min read
STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise
STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights